Subscribe for the Newsletter

Mobile Navigation

Early Targeting of Chronic Inflammation That Precedes and Causes Synaptic Loss

Jul 29, 2021PTV-07-21-CL-001

On this episode of Pharma's Almanac TV, our Scientific Editor in Chief, David Alvaro, talks to INmune Bio's President and CEO Raymond J. Tesi about the company's unique and revolutionary treatment of chronic inflammation that causes Alzheimer's.

Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.
Subscribe for the newsletter
© 2026 PHARMA'S ALMANAC. All rights reserved.